Innoviva, Inc. filings document a Nasdaq-listed common-stock issuer with a royalty healthcare portfolio, Innoviva Specialty Therapeutics operations, and strategic healthcare investments. Form 8-K reports furnish operating results and financial condition, including royalty revenue, IST net product sales, product-portfolio developments, fair-value changes in investments, and capital allocation activity.
Proxy and annual-meeting filings cover board elections, advisory executive-compensation votes, auditor ratification, and equity incentive plan approvals. The record also identifies the company’s common stock, par value $0.01 per share, traded under INVA on the Nasdaq Global Select Market.
Marianne Zhen, Chief Accounting Officer of Innoviva, Inc. (INVA), reported a disposition of company stock on 08/20/2025. The Form 4 shows 991 shares were disposed at a price of $19.95 per share, leaving 49,329 shares beneficially owned after the transaction. The filing explains the shares were withheld by the issuer to satisfy income tax withholding related to the quarterly vesting of previously granted employee equity awards.
Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation report beneficial ownership of 4,760,832 shares of Innoviva, Inc. common stock (CUSIP 45781M101), representing 7.56% of the outstanding class. The filing shows the reporting persons have sole voting and sole dispositive power over these shares. The statement is made on a Schedule 13G/A and includes a certification that the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. Certain funds managed by Renaissance may have rights to dividends or sale proceeds related to these securities.
Franklin Resources, Inc. and its principals Charles B. Johnson and Rupert H. Johnson, Jr. filed Amendment No. 2 to Schedule 13G on 08/01/2025 covering Innoviva, Inc. (INVA) common stock as of 06/30/2025.
- Ownership: 2,827,918 shares beneficially owned, equal to 4.5 % of outstanding shares.
- Control: Sole voting power – 2,583,688 shares; sole dispositive power – 2,827,918 shares; no shared voting or dispositive power.
- Threshold change: Item 5 confirms ownership has fallen to “5 percent or less,” indicating the group is now below the 5 % reporting threshold.
- Reporting persons: Franklin Resources (DE), Charles B. Johnson, and Rupert H. Johnson, Jr.; all file as holding company/control persons (Type HC, CO/IN).
- Purpose: Securities are held in the ordinary course by investment‐management subsidiaries; the filing states no intent to influence control of Innoviva.
The amendment mainly updates share counts and affirms that the institutional investor’s aggregate stake has decreased to a non-activist, sub-5 % level.